← FDA DRUG APPROVALS

FDA ANDA · ANDA076969

METOPROLOL SUCCINATE

Sponsor: SANDOZ

APPLICATION
ANDA076969
TYPE
ANDA
ORIGINAL APPROVAL
2006-07-31
LATEST ACTION
2007-05-18
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

METOPROLOL SUCCINATEDiscontinued
METOPROLOL SUCCINATE EQ 50MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL
METOPROLOL SUCCINATEDiscontinued
METOPROLOL SUCCINATE EQ 100MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL
METOPROLOL SUCCINATEDiscontinued
METOPROLOL SUCCINATE EQ 25MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL
METOPROLOL SUCCINATEDiscontinued
METOPROLOL SUCCINATE EQ 200MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL

Approval history

2007-05-18Labeling · Supplement 3 — Letter ↗AP
2007-05-18Manufacturing (CMC) · Supplement 2 — Letter ↗AP
2006-07-31Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →